Európai Unió - izlandi - EMA (European Medicines Agency)

pierre fabre medicament - própranólól hýdróklóríð - hemangioma - betablokkar - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.

Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - propranololum hýdróklóríð - tafla - 40 mg

Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

actavis group ptc ehf. - propranololum hýdróklóríð - tafla - 80 mg

Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

viatris aps - verapamilum hýdróklóríð - forðatafla - 120 mg

Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - rizatriptanum benzóat - munndreifitafla - 10 mg

Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

n.v. organon* - rizatriptanum benzóat - frostþurrkuð tafla - 10 mg

Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - rizatriptanum benzóat - munndreifitafla - 10 mg

Izland - izlandi - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - rizatriptanum benzóat - munndreifitafla - 5 mg

Európai Unió - izlandi - EMA (European Medicines Agency)

eli lilly nederland b.v. - lasmiditan succinate - mígreni kvilla - verkjalyf - rayvow is indicated for the acute treatment of the headache phase of migraine attacks, with or without aura in adults.

Európai Unió - izlandi - EMA (European Medicines Agency)

servier (ireland) industries ltd - agomelatine - Þunglyndi, major - psychoanaleptics, - meðferð við alvarlegum þunglyndisþáttum hjá fullorðnum.